Sechelt Organic Marijuana Corp

Sechelt Organic Marijuana Corp was a Canadian medical cannabis company and a subsidiary of Veritas Pharma Inc. Based in Sechelt, British Columbia, the company was established to cultivate and produce organic, medical-grade cannabis strains using a unique "no till" growing technique. Its primary mission was to support the development of proprietary cultivars for the treatment of conditions such as chronic pain, nausea, epilepsy, and PTSD. The company operated as the production arm for Veritas's research-driven pipeline, which included the lead strain CTL-X. Despite reaching advanced stages of the Health Canada licensing process, the company's production facility was never fully realized. In 2019, the parent company sold the Sechelt property due to regulatory changes, effectively ending the subsidiary's operations.